Eriksson J W, Smith U, Waagstein F, Wysocki M, Jansson P A
Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Göteborg, Sweden.
Diabetes. 1999 Aug;48(8):1572-8. doi: 10.2337/diabetes.48.8.1572.
To elucidate potential mechanisms for insulin resistance occurring early in the development of type 2 diabetes, we studied 10 young healthy individuals, each with two first-degree relatives with type 2 diabetes, and 10 control subjects without known type 2 diabetic relatives. They were pairwise matched for age (35 +/- 1 vs. 35 +/- 1 years), BMI (23.6 +/- 0.6 vs. 23.1 +/- 0.4 kg/m2), and sex (four men, six women). Glucose turnover was assessed during a euglycemic clamp at two insulin levels (low approximately 20 mU/l; high approximately 90 mU/l), and abdominal subcutaneous adipose tissue (SAT) lipolysis and blood flow were concomitantly studied with microdialysis and 133Xe clearance. HbA1c was higher in patients with type 2 diabetic relatives than in control subjects (4.8 +/- 0.1 vs. 4.5 +/- 0.1%, P < 0.02), but fasting glucose, insulin, and C-peptide levels were similar. During the clamp, the insulin sensitivity index for glucose disposal was lower (P < 0.03) in relatives than in control subjects (low 12.0 +/- 1.6 vs. 18.1 +/- 1.4; high 9.4 +/- 0.8 vs. 12.9 +/- 0.6 [100 x mg x l x kg(-1) x mU(-1) x min(-1)]). This difference was partially attributed to slightly higher clamp insulin levels in the relatives (P < 0.03), suggesting an impaired rate for insulin clearance. SAT lipolysis measured as in situ glycerol release did not differ under basal conditions (2.0 +/- 0.2 vs. 2.1 +/- 0.2 micromol x kg(-1) x min(-1)), but the suppression during the insulin infusion was less marked in relatives than in control subjects (glycerol release: low 0.92 +/- 0.09 vs. 0.68 +/- 0.16; high 0.71 +/- 0.10 vs. 0.34 +/- 0.10 micromol x kg(-1) x min(-1); P < 0.03). Plasma nonesterified fatty acids also tended to be higher in relatives than in control subjects during the insulin infusion (NS). In contrast, in vitro experiments with isolated subcutaneous adipocytes displayed similar effects of insulin in relatives and control subjects with respect to both glucose uptake and antilipolysis. In conclusion, insulin action in vivo on both lipolysis and glucose uptake is impaired early in the development of type 2 diabetes. Since this impairment was not found in isolated adipocytes, it may be suggested that neural or hormonal perturbations precede cellular insulin resistance in type 2 diabetes.
为阐明2型糖尿病发生早期胰岛素抵抗的潜在机制,我们研究了10名年轻健康个体,他们每人有两名2型糖尿病的一级亲属,以及10名无2型糖尿病亲属的对照受试者。他们在年龄(35±1岁对35±1岁)、体重指数(23.6±0.6kg/m²对23.1±0.4kg/m²)和性别(4名男性,6名女性)方面进行了配对。在两种胰岛素水平(低约20mU/l;高约90mU/l)的正常血糖钳夹期间评估葡萄糖周转率,并同时用微透析和¹³³Xe清除法研究腹部皮下脂肪组织(SAT)的脂肪分解和血流情况。有2型糖尿病亲属的患者糖化血红蛋白(HbA1c)高于对照受试者(4.8±0.1%对4.5±0.1%,P<0.02),但空腹血糖、胰岛素和C肽水平相似。在钳夹期间,亲属的葡萄糖处置胰岛素敏感性指数较低(P<0.03),低于对照受试者(低胰岛素水平时为12.0±1.6对18.1±1.4;高胰岛素水平时为9.4±0.8对12.9±0.6[100×mg×l×kg⁻¹×mU⁻¹×min⁻¹])。这种差异部分归因于亲属的钳夹胰岛素水平略高(P<0.03),提示胰岛素清除率受损。以原位甘油释放量衡量的SAT脂肪分解在基础条件下无差异(2.0±0.2对2.1±0.2μmol×kg⁻¹×min⁻¹),但在胰岛素输注期间亲属的抑制作用不如对照受试者明显(甘油释放量:低胰岛素水平时为0.92±0.09对0.68±0.16;高胰岛素水平时为0.71±0.10对0.34±0.10μmol×kg⁻¹×min⁻¹;P<0.03)。在胰岛素输注期间,亲属的血浆非酯化脂肪酸也往往高于对照受试者(无统计学差异)。相反,对分离的皮下脂肪细胞进行的体外实验显示,亲属和对照受试者的胰岛素在葡萄糖摄取和抗脂肪分解方面具有相似的作用。总之,在2型糖尿病发生早期,体内胰岛素在脂肪分解和葡萄糖摄取方面的作用受损。由于在分离的脂肪细胞中未发现这种损伤,提示在2型糖尿病中神经或激素紊乱先于细胞胰岛素抵抗出现。